Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.300
+0.010 (0.44%)
At close: Feb 5, 2026
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 417.49 million as of February 5, 2026. Its market cap has increased by 93.04% in one year.
Market Cap
417.49M
Enterprise Value
403.82M
Revenue
6.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.30
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 417.49M, an increase of 3,203.65%. That is a compound annual growth rate of 44.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 415.62M | -15.80% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PYC Therapeutics | 933.22M |
| Opthea | 738.77M |
| Immutep | 596.86M |
| Clinuvel Pharmaceuticals | 549.20M |
| Dimerix | 306.20M |
| Orthocell | 257.74M |
| Tetratherix | 202.05M |
| Botanix Pharmaceuticals | 197.01M |